Kailas Salunkhe

About the Author Kailas Salunkhe


Crinetics Pharmaceuticals Stock Is Showing Strong Insider Interest

Clinical-stage pharmaceutical company Crinetics Pharmaceuticals Inc. (CRNX) has seen a key corporate insider snap up shares recently.

Middleby Snaps Up Welbilt; Shares Fall 7.5% Pre-Market

The Middleby Corp. has agreed to acquire Welbilt Inc.

Major Insider Transactions In Nexstar Stock Sends Strong Signal To Investors

Television broadcasting and digital media company Nexstar Media Group (NXST) has seen a flurry of both buying and selling of company shares by …

Insider Buying Of Molecular Templates Stock Corresponds With Analyst Ratings

Clinical-stage biopharmaceutical company Molecular Templates (MTEM) has seen multiple informed key insider purchases over the past few weeks. Whenever insiders such as top …

Marchex Stock Is Showing Strong Insider Interest

Call analytics company Marchex Inc (MCHX) has seen 2 separate stock purchases by a key stakeholder in the past month. Keeping tabs on …

Whirlpool Corp Increases Share Buyback by $2 Billion, Hikes Quarterly Dividend By 12%

Kitchen and laundry appliance maker Whirlpool Corp. has announced a share repurchase program of $2 billion.

Amgen’s Bemarituzumab Receives Breakthrough Therapy Designation

Amgen’s investigational treatment bemarituzumab has received Breakthrough Therapy Designation from the U.S.

Corporate Insiders Snap Up Shares of Liquidia Technologies

Biopharmaceutical company Liquidia Technologies (LQDA) has seen two corporate insiders pull the trigger on shares in the past week. Insiders such as corporate …

Afya Snaps Up Cliquefarma

Medical education group Afya Ltd. has acquired health tech company Cliquefarma.

Eli Lilly And Incyte’s Baricitinib Fails To Meet Endpoint In Phase 3 COVID-19 Trial

Eli Lilly and Co. And Incyte reported data from their phase 3 study of baricitinib in hospitalized COVID-19 patients.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts